ACSL4 has high expression in HCC, promoting HCC survival and inhibition of apoptosis through O-GlcNAcylation, which is dependent on solute carrier family 2 member 1 (SLC2A1) [74]. The gene discussed is SLC1A2; the disease is hepatocellular carcinoma.